LEP and metabolic dysfunction-associated steatohepatitis: Increased angiogenesis lead by leptin has been demonstrated in rats, where leptin-mediated neovascularization coordinated with VEGF plays an important role in the development of liver fibrosis and hepatocarcinogenesis in NASH [180].